GlobeNewswire by notified

World-Class Experts in Hospitality Investment Take the Stage at Questex’s IHIF EMEA 2024

Share

Event Takes Place 15-17 April at the InterContinental and Pullman hotels in Berlin

LONDON, April 15, 2024 (GLOBE NEWSWIRE) -- Questex’s International Hospitality Investment Forum EMEA (IHIF EMEA) commenced with presentations from world-class experts in hospitality investment. The event takes place at the InterContinental and Pullman hotels in Berlin through 17 April 2024. With over 2,500 attendees attending IHIF EMEA 2024, it is one of the largest gatherings of industry professionals in the region.

“Day one at IHIF is always energetic, and today was no different. With over 2,500 of the sector’s best and brightest arriving today there was a lot of networking, meetings, and excitement around the exhibition areas. The content sessions were all packed as speakers like James Pomeroy, HSBC, Elie Malouf, CEO IHG Hotels & Resorts, Mark Hoplamazian, CEO Hyatt Hotels, Federico Gonzalez, CEO Radisson Hotels, Sebastian Bazin, CEO Accor and Guy Verhofstadt former Prime Minister of Belgium spoke today,” says Alexi Khajavi, Group President Travel & Hospitality, Questex.

IHIF EMEA 2024 kicked off with the Investor Council meeting during which investors expressed optimism on the direction of the transactions market compared to six months ago but noted that growing geopolitical tensions present a serious risk to both consumer demand and investment. Despite these tensions as well as pressures in relation to the labour market, investors continue to seek to increase their allocation to hospitality as hotels continue to enjoy revenues way ahead of 2019 levels, with several members of the council spotlighting the lifestyle segment as being very attractive.

On the main stage, the first day of speakers focused on the macro. Despite the short-term geopolitical challenges there was talk of the growing middle class across the world, especially in countries like India with HSBC’s global economist James Pomeroy, highlighting the trend: “International travel in particular will see Indian consumer demand grow 12% per year, every year, for the next 20 years. This economy will completely transform the way we think about global growth,” Pomeroy said.

IHG Hotel Resorts CEO Elie Maalouf said that a “wave of retirements” coming now and “which will go on for decades of the healthiest and wealthiest generations ever” is set to drive international leisure travel.

Announcements from IHIF partners:

  • Global Hotel Alliance (GHA), the world’s largest alliance of independent hotel brands, has started its 20th anniversary year on a high note, reporting robust Q1 results across all key performance indicators. [Press release]
  • Grand Metropolitan Hotels adds over 130 hotels to its portfolio with the establishment of its own brands for the African market and the inclusion of Rainbow Hotels, Grand Metropolitan Hotels now becomes one of the leading providers in Africa. [Press release
  • Room Mate Hotels, a hotel chain born in Spain in 2005 with a strong international presence, launches its new image and a second brand “Room Mate Collection” pursuing “silent luxury.” [Press release]
  • Marriott International, Inc. announced plans to add nearly 100 properties and over 12,000 rooms to its portfolio in Europe portfolio through hotel conversions and adaptive reuse projects, the conversion of existing buildings into a hotel, by the end of 2026. [Press release]

For more information about IHIF EMEA 2024 and to register for the event, visit IHIF EMEA website.

For a list of companies attending, please click here.

Stay connected with IHIF EMEA on X and LinkedIn.

About Questex

Questex helps people live better and longer. Questex brings people together in the markets that help people live better: travel, hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy – connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.

Media Contact

Francesca Ruggiero

Senior Marketing Manager, Hotel Group

Questex

fruggiero@questex.com

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Subsea7 awarded a contract for the Belinda field in the UK North Sea25.5.2024 14:01:09 CEST | Press release

Luxembourg – 25 May 2024 - Subsea7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the award of a sizeable1 contract by Serica Energy, for the Belinda field development south-east of the Triton FPSO. The Belinda field is operated by Serica Energy and located approximately 190 kilometres east of Aberdeen in the UK Central North Sea, with a water depth of 95 metres. The contract scope includes project management, engineering, procurement, construction and installation (EPCI) of a 5-kilometre 8” production pipeline with a 3” piggy-backed gas lift line and an electro-hydraulic controls (EHC) umbilical. Subsea7’s scope also includes associated subsea structures and tie-ins to the Triton Floating Production Storage & Offloading (FPSO) vessel operated by Dana Petroleum, via an existing production manifold near the Triton riser base and for controls at the Evelyn valve skid. Project management and engineering work will commence immediately in Aberdeen. The offshore activities are scheduled

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio25.5.2024 12:15:00 CEST | Press release

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor,demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs. placebo + supportive care at 36 weeks1 Endothelin A (ETA) receptor activation contributes to elevated proteinuria in IgAN2-5; atrasentan is a potent, selective ETA receptor antagonist with potential to reduce persistent proteinuria and preserve kidney function for a broad patient population1 IgAN is a heterogeneous, progressive, rare kidney disease with a need for effective, targeted therapies6,7; up to 30% of patients with persistent proteinuria (≥1 g/day) progress to kidney failure within 10 years8 Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression Basel, May 25, 2024 – Novartis today presented results from a pre-specified interim analysis of the Phase III ALIGN study of atr

Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo25.5.2024 12:00:00 CEST | Press release

Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label data to be presented at a future medical meeting2,3Fabhalta showed a favorable safety profile with no new safety signals1C3G, an ultra-rare kidney disease caused by alternative complement pathway overactivation, progresses to kidney failure in ∼50% of patients within 10 years4-7; currently there are no treatments approved for C3G7-9 Fabhalta, an oral Factor B inhibitor of the alternative complement pathway, selectively targets the underlying cause of C3G1; late-stage development program ongoing across several other rare diseases10-13 Basel, May 25, 2024 – Novartis today presented results from the 6-month, double-blind period of the Phase III APPEAR-C3G study of Fabhalta® (iptacopan) at the late-breaking clinical trials session of the European Renal Association (ERA) Congress1. Patients treated with Fabhalta in addition to support

Metasphere Labs Announces Development of Innovative Carbon Credit Protocol for Grid-Scale Batteries24.5.2024 22:05:00 CEST | Press release

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Metasphere Labs Inc. (formerly Looking Glass Labs Ltd., "Metasphere" or the "Company") (Cboe Canada: LABZ) (OTC: LABZF) (FRA: H1N) is excited to announce an innovative initiative aimed at accelerating the decarbonization of the electricity grid through the development of a pioneering carbon credit protocol for grid-scale batteries. Innovative Carbon Credit Protocol The Company is committed to leveraging advanced technology to address critical environmental challenges. The new carbon credit protocol will enable grid-scale batteries to monetize their environmental attributes by generating carbon credits for the carbon reductions achieved through optimized battery operations. This protocol is designed to incentivize the deployment and operation of grid-scale batteries, ensuring they play a pivotal role in the transition to a clean energy future. Submission to Pure Sky Carbon Credit Registry The Company intends to submit this pr

Nokia Corporation: Repurchase of own shares on 24.05.202424.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 24 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 24.05.2024 Espoo, Finland – On 24 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL362,1533.55CEUX--BATE--AQEU--TQEX--Total362,1533.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

HiddenA line styled icon from Orion Icon Library.Eye